"In that situation, most people regret having taken the medication and wish that they had never heard of it because they're out the money and they are at the same weight or higher than when they started." For that reason, doctors like Persaud who treat obesity are glad generics are finally on the way though he says Canadians shouldn't have to wait until patents expire to access life-changing drugs like GLP-1s
Sumithran P, Prendergast LA, Delbridge E, Purcell K, Shulkes A, Kriketos A et al
Zou W, Yue P, Lin N, He M, Zhou Z, Lonial S, Khuri FR, Wang B, Sun SY
GLP-1 receptor agonist medicines, also called incretin mimetics, are a type of incretin-based medicine for type 2 diabetes
Discussion Since the finding that the thiazolidinedione rosiglitazone increased cardiovascular events, much weight has been placed on the safety of novel glucose-lowering drugs
[1] [2] These medications mimic the action of naturally occurring GLP-1, a hormone produced in the intestine that plays a crucial role in glucose regulation and appetite control